Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy
NRAS突变型黑色素瘤中二价染色质状态的重编程提示PRC2抑制可能是一种治疗策略。
期刊:Cell Reports
影响因子:7.5
doi:10.1016/j.celrep.2021.109410
Christopher J Terranova ,Ming Tang ,Mayinuer Maitituoheti ,Ayush T Raman ,Archit K Ghosh ,Jonathan Schulz ,Samir B Amin ,Elias Orouji ,Katarzyna Tomczak ,Sharmistha Sarkar ,Junna Oba ,Caitlin Creasy ,Chang-Jiun Wu ,Samia Khan ,Rossana Lazcano ,Khalida Wani ,Anand Singh ,Praveen Barrodia ,Dongyu Zhao ,Kaifu Chen ,Lauren E Haydu ,Wei-Lien Wang ,Alexander J Lazar ,Scott E Woodman ,Chantale Bernatchez ,Kunal Rai